New Data By Pfizer Suggests That A Third Dose Of The Vaccine Will Be Helpful In Protecting Against The Delta Variant

This post may contain affiliate links. For more information, please read our disclosure policy here

Many Americans are doing their part to eradicate the COVID-19 virus by getting vaccinated.

They are getting the standard 2-dose vaccine that promised protection against the harsh side effects from catching the coronavirus.

(Unless they got the Johnson & Johnson version of the vaccine, which is a one-dose vaccination)

But, then this nasty Delta variant popped up, and now we are all questioning whether getting this two-dose vaccine was indeed helpful against all variants of the coronavirus.

Let me preface this by saying: I am not a doctor.

Also, this data has not been peer reviewed or officially published, so take it for what it is — recommendations by the company who produces the Pfizer vaccine.

Pfizer has posted data online that strongly suggests that the public get a THIRD booster shot of the vaccine.

[The data] suggest that antibody levels against the delta variant in people ages 18 to 55 who receive a third dose of vaccine are greater than five-fold than following a second dose.

ABC7 Chicago

I mean, I just barely made the decision to bite the bullet and get the two-dose vaccine. Now they are saying I need a THIRD dose?

I am not so sure about that. The side effects from the second vaccine were pretty gnarly in my system (everyone reacts differently to the vaccine). I’m worried about what a third dose would do.

The Pfizer data is saying that persons 65 to 85 really responded positively to a third dose.

Antibody levels against the Delta variant after receiving a third dose of vaccine [is shown to be] greater than 11-fold than following a second dose.

ABC7 Chicago

There has also been a Beta version of the virus pop up, first in South Africa, and this third dose of the vaccine has been shown to produce more antibodies for this version of the virus.

Of course, a third dose of the Pfizer vaccine would also produce more antibodies against the original virus.

(Wasn’t the second dose for that?)

There’s an “estimated potential for up to 100-fold increase in delta neutralization post-dose three compared to pre-dose three,” researchers wrote in the Pfizer data slides.

ABC7 Chicago

Although Pfizer has published this information online, they are expected to discuss the efficacy of a third vaccine during their next earnings call.

So, what do you think? Is a THIRD Pfizer dose in your future?

No word on whether the company who produces the Moderna vaccine will follow suit in recommending a third “booster” shot.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *